US FDA Planning Another Patient Group To Boost Involvement
Patient Engagement Collaborative expected to invite stakeholders to discuss how patient interaction with FDA can improve.
You may also be interested in...
Rachel Sherman says agency is creating patient affairs staff, but will not undergo reorganization to create an official office.
Will a meeting with the agency's new principal deputy commissioner help assure creation of new access point for patient engagement?
FDA floats idea of central office to coordinate patient engagement for symbolic as well as practical reasons.